SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0000950123-98-005423
Filing Date
1998-05-27
Accepted
1998-05-27 00:00:00
Documents
7
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM F-3 F-3/A 357884
2 SPECIMEN CERTIFICATE OF COMMON SHARES EX-4.2 9633
3 OPINION OF STIKEMAN, ELLIOTT, INCLUDING CONSENT EX-8.1 3241
4 OPINION OF KIRKLAND & ELLIS, INCLUDING CONSENT EX-8.2 2799
5 AMENDMENT NO. 1 TO TECHNOLOGY LICENSE AGREEMENT EX-10.7 3164
6 CONSENT OF ERNST & YOUNG, EX-23.1 554
7 FINANCIAL DATA SCHEDULE EX-27.1 2398
  Complete submission text file 0000950123-98-005423.txt   381749
Mailing Address 275 ARMAND FRAPPIER BLVD LAVAL QUEBEC E6
Business Address 275 ARMAND-FRAPPIER BLVD LAVAL QUEBEC E6 5146811744
BIOCHEM PHARMA INC (Filer) CIK: 0000867202 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E6 | Fiscal Year End: 0131
Type: F-3/A | Act: 33 | File No.: 333-48521 | Film No.: 98631815
SIC: 2835 In Vitro & In Vivo Diagnostic Substances